louisiana semaglutide bowel obstruction lawsuit class action in Wegovy What Are the Claims in

National Institutes of Health (NIH): "Sleep Apnea Overview." NIH, National Heart, Lung, and Blood Institute

Semaglutide has emerged as one of the most studied weight loss medications, with landmark trials showing average reductions of 1022% of initial body weight

FDA-approved GLP-1s like Wegovy, Ozempic, Mounjaro, and Zepbound offer certainties that compounded versions simply cant, including: Consistent, tested ingredients in every dose Manufacturing facilities that meet strict quality standards Pre-filled pens that deliver precise amounts every time Comprehensive tracking of side effects Long-term studies on safety and effectiveness Regular inspections of manufacturing facilities Standardized patient information and warning labels With compounded versions, the risks are very real

To minimize potential GI side effects and support tolerability, oral semaglutide should be initiated at 3 mg once daily for 30 days

Prices vary depending on pharmacy and location

Algon AAA, Almulla A, Najm AH, Keshwan RA